SBIR/STTR Research Award

Personalized Smoking Cessation Tool based on patient lung CT image

Award identifier 4b9178f0388a053f317e9f2b93972477cf611367f467a591aa2eb6f65e94ef31Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$179,105

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Imbio, LLC
Proposal award date
2015-09-23
Contract end date
2016-03-22
UEI
FNB6YYCELKU5
Solicitation number
PA14-071
Topic code
102

Research abstract

DESCRIPTION provided by applicant In this project we proposes to design a patient report based on Imbioandapos s Lung Density Analysis a CT image processing application that will increase a patientandapos s motivation to make a quit attempt by providing compelling visual feedback on the state of their lung health comparative data with peers and individualized predictions of long term health Lung cancer is the leading cause of cancer related deaths in the U S with approximately percent of all cases in the U S attributable to smoking tobacco The total economic cost due to tobacco in the U S is over $ billion a year which includes at least $ billion in direct medical care Recent U S government reimbursement policy decisions to provide screening for high risk current and former smokers presents an opportunity to advance smoking cessation interventions that motivate quit attempts and ultimately long term abstinence Studies indicate that smoking cessation tools should be incorporated into lung cancer screening programs for both cost effectiveness and quality of life improvement Imbioandapos s Lung Density Analysis TM LDA is a CT image processing application that quantifies the extent of tissue damage in patients Specifically LDA creates reports for physicians that improve visualization of pulmonary tissue areas with abnormal density associated with emphysema and provide objective quantitative measures of these areas LDA is compatible with recommended lung cancer screening protocols and offers a scalable cost effective solution for centers ranging from minimal to significant patient volume It is hypothesized that creating a new Imbio report for patients with individualized information about lung health and personal risks with additional information focused on smoking cessation will increase motivation to quit smoking Specifically the report will have five sections of information addressing all components of the Health Belief Model Image Section which will provide visual feedback and quantitative results Comparative Section which will provide a mapping of the patientandapos s lung status to a corresponding cohort of participants in a large clinical trial database that includes comparable lung CT exams Health Outcomes Section which will provide information about the long term health outcomes for the associated participant cohort Quit Now section which will outline benefits of making a quit attempt and Outreach section which will provide contact information for smoking cessation support Through individual interviews the Imbio Smoking Cessation Report will be optimized to ensure it can be readily understood by the average layperson Focus groups will then be conducted to optimize the psychological impact of the Imbio Smoking Cessation Report to encourage quit attempts The Imbio Smoking Cessation Report will be the only smoking cessation product in the market providing truly personalized information and comparative detail PUBLIC HEALTH RELEVANCE The goal of this project is to design a patient report based on Imbioandapos s Lung Density Analysis a CT image processing application that will increase a patientandapos s motivation to make a quit attempt by providing compelling visual feedback on the state of their lung health comparative data with peers and individualized predictions of long term health The resulting Imbio Smoking Cessation Report will be the only smoking cessation product in the market providing truly personalized information and comparative detail Through individual interviews and focus groups the Imbio Smoking Cessation Report will be optimized to ensure comprehensibility and psychological impact

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

14 SBIR/STTR records share this UEI (2013–2022). Reported award amounts total $10,686,328. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.